Form 4: Director Brent D. Lang Receives Outset Medical Equity Grant

Director Brent D. Lang was granted 10,667 restricted stock units (RSUs) by Outset Medical, Inc. on June 4, 2026.

Summary

• Director Brent D. Lang acquired 10,667 shares of common stock in the form of restricted stock units (RSUs).
• The grant was issued at a price of $0.0 per share.
• Following this transaction, the reporting person holds 28,518 shares directly and 16,666 shares indirectly via the Lang Family Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The RSUs are scheduled to vest on the earlier of the one-year anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure board members maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The grant structure is consistent with standard equity compensation practices for independent directors in the medical device sector.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 10,667 RSUs on the earlier of June 4, 2027, or the date of the next Annual Meeting of Stockholders.

Key Dates

Keywords

Outset Medical, OM, Form 4, Insider Trading, Equity Grant, Brent D. Lang